Barclays
QUIT icon

Barclays’s Achieve Life Sciences QUIT Stock Holding History

Barclays’s Portfolio QUIT Stock Details QUIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$293K Buy
36,217
+16,223
+81% +$116K ﹤0.01% 3754
2026
Q2 		$131K Sell
19,994
-28,073
-58% -$134K ﹤0.01% 3929
2026
Q1 		$141K Sell
48,067
-61,965
-56% -$275K ﹤0.01% 3880
2025
Q4 		$547K Buy
110,032
+110,031
+11,003,100% +$480K ﹤0.01% 3792
2025
Q3 		$3 Sell
1
-1,715
-100% -$4.71K ﹤0.01% 5422
2025
Q2 		$3.88K Sell
1,716
-34,585
-95% -$98.5K ﹤0.01% 4994
2025
Q1 		$96.9K Sell
36,301
-17,172
-32% -$53.4K ﹤0.01% 4425
2024
Q4 		$188K Buy
53,473
+5,818
+12% +$26.4K ﹤0.01% 4343
2024
Q3 		$226K Buy
47,655
+35,832
+303% +$164K ﹤0.01% 4230
2024
Q2 		$55.6K Buy
+11,823
New +$57K ﹤0.01% 4167
2020
Q2 		– Sell
-5,671
Closed -$37K – 5489
2020
Q1 		$37K Buy
5,671
+5,670
+567,000% +$54.8K ﹤0.01% 5385
2019
Q4 		$0 Buy
+1
New +$21 ﹤0.01% 6301
2014
Q4 		– Hold
0
– – – 7221
2014
Q3 		– Sell
-19
Closed -$132K – 7631
2014
Q2 		$125K Buy
+19
New +$233K ﹤0.01% 5245
2014
Q1 		– Sell
-4
Closed -$98.3K – 7062
2013
Q4 		$74K Buy
+4
New +$70.2K ﹤0.01% 5896
2013
Q3 		– Sell
-2
Closed -$41.4K – 6817
2013
Q2 		$51K Buy
+2
New +$44.7K ﹤0.01% 6290

Other funds holding QUIT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Barclays's QUIT Position: Q3 2026 in Review

Barclays increased its Achieve Life Sciences (QUIT) stake by 81% in Q3 2026, buying an estimated $116K and bringing the position to 36,217 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

Barclays first reported a position in QUIT in Q2 2013 and has held it in 15 quarters since. The position peaked at $547K in Q4 2025. 42 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • Barclays held 36,217 shares of Achieve Life Sciences worth $293K as of Q3 2026.
  • Barclays bought 16,223 Achieve Life Sciences shares in Q3 2026, an estimated $116K.
  • Achieve Life Sciences made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3754 holding.
  • Barclays first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 15 quarters since.
  • Barclays's Achieve Life Sciences position peaked at $547K in Q4 2025.
  • 42 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.